Mesonephric duct development

pathway activity — cross-omics
GO:0072177Cross-omicsSHRNA → SHRNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Mesonephric duct development pathway is significantly associated with the shRNA dependency of multiple genes, with the BREAST cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GPC3, WNT11, and MYOG, each associated with the pathway in up to 13 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, GPC3 grouped by Mesonephric duct development-low versus -high activity in BREAST.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BREASTGPC3 →-0.381-1.275.002<.001313
STOMACHWNT11 →-0.228-1.113<.001.00238
SKINMYOG →-0.135-0.960.003.00735
LARGE_INTESTINEHNF1B →-0.320-1.308<.001<.00135
PANCREASWNT9B →-0.146-0.840.005.00326
LUNG_NSCLC_LUADPAFAH1B3 →-0.186-1.263<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GPC3 by Mesonephric duct development activity — BREAST

Box plot of GPC3 in Mesonephric duct development-low vs -high samples in BREAST.

Explore this box plot interactively →

Exploration